Saudi Arabia Radiation Oncology Market Size & Outlook

The radiation oncology market in Saudi Arabia is expected to reach a projected revenue of US$ 71.4 million by 2028. A compound annual growth rate of 7.7% is expected of Saudi Arabia radiation oncology market from 2021 to 2028.
Revenue, 2020 (US$M)
$39.4
Forecast, 2028 (US$M)
$71.4
CAGR, 2021 - 2028
7.7%
Report Coverage
Saudi Arabia

Saudi Arabia radiation oncology market highlights

  • The Saudi Arabia radiation oncology market generated a revenue of USD 39.4 million in 2020 and is expected to reach USD 71.4 million by 2028.
  • The Saudi Arabia market is expected to grow at a CAGR of 7.7% from 2021 to 2028.
  • In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
  • Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.


Radiation oncology market data book summary

Market revenue in 2020USD 39.4 million
Market revenue in 2028USD 71.4 million
Growth rate7.7% (CAGR from 2020 to 2028)
Largest segmentExternal beam radiationtherapy
Fastest growing segmentInternal Beam Radiation Therapy
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationExternal Beam RadiationTherapy, Internal Beam Radiation Therapy
Key market players worldwideSiemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.5% of the global radiation oncology market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Middle East & Africa, South Africa radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 71.4 million by 2028.

External beam radiationtherapy was the largest segment with a revenue share of 78.68% in 2020. Horizon Databook has segmented the Saudi Arabia radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.


Saudi Arabia is estimated to grow at a high CAGR over the forecast period owing to various factors such as increase in research initiatives. For instance, in October 2019, King Abdullah University of Science and Technology (KAUST) and King Abdul Aziz University (KAU) collaborated for funding and research of innovative cancer treatment. 

Furthermore, rising prevalence of cancer is anticipated to drive the market growth. According to WHO (2018), the 5- year prevalence of cancer was 70,819 in Saudi Arabia. Moreover, there is an unmet need for cancer treatment in the region.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiation Oncology Market Companies

Name Profile # Employees HQ Website

Saudi Arabia radiation oncology market size, by type, 2017-2028 (US$M)

Saudi Arabia Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)

Saudi Arabia radiation oncology market size, by type, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more